HMGB1 and pulmonary arterial hypertension: The elevation of pro-inflammatory HMGB1 in the early stage of MCT-induced PAH led us to hypothesize that HMGB1 might be an initiating factor for PAH, and that blocking HMGB1 activity using the anti-HMGB1 antibody could prevent development of PAH.